ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BXP Beximco Pharma

36.50
0.00 (0.00%)
01 May 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Beximco Pharma LSE:BXP London Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 36.50 35.00 38.00 36.50 36.50 36.50 11,414 08:00:00

Beximco Pharma Discussion Threads

Showing 976 to 998 of 2150 messages
Chat Pages: Latest  50  49  48  47  46  45  44  43  42  41  40  39  Older
DateSubjectAuthorDiscuss
30/4/2014
09:40
Cash Dividend!
This should narrow the share price gap.

sharpshare
30/4/2014
09:32
Nice reward for shareholders

RNS 30th April 2014

giant steps
30/4/2014
09:02
Not even a month Davy, only three weeks! Its possible the seller is still from the old regime so doesn't care about the fundamentals here. They just want out.

They can't have much left though as the MM's mark the price up after the trade.

The new holders will be rubbing their hands here as they know longer term they are onto a good thing at this entry point. Bangladesh is one of the few ecomonies left where there is major growth opportunities for foreign investors as India and China have restrictions on overseas ownership.

Will be an interesting few weeks here as any buying momentum will see this pushed higher.

237gmoney
30/4/2014
08:44
Selling at 14.18p a month before a 15% dividend. The stockmarket never stops surprising me.
davydoo
30/4/2014
08:27
I am happy with that. Perfect summary 237gmoney.
davydoo
30/4/2014
08:23
Yes Gpad another 15% dividend which was roughly what I was expecting although 10% in cash is a new strategy which means less dilution for existing shareholders.

Record date is 18 may so plenty of time to get an easy 15% bonus here with limited downside as we are already undervalued based on the Dhaka shareprice and unlikely to be any major selloff before results are out as we have a new set of major shareholders.

4.01 EPS as well so the company is still running really well. Definitely an undervalued play with all the current M&A actiivity out there in the Pharma sector.

Not many of these little gems out there!

237gmoney
30/4/2014
08:11
From Notice of Preliminary results.

5% Stock Dividend and 10% Cash Dividend, have I read that correctly?

That looks pretty good to me!.

gp

gpadfoot
23/4/2014
14:51
Only a week to go now until the Notification of Preliminary Results and Annual General Meeting RNS is out. Likely board meeting to sign off early next week or later this week.

The last two years here there has been an RNS announcing the results will be out around the 14/15th May with a stock dividend with a record date on either 20/21st May.

Quite a bit of consolidation in the Pharma sector recently and there is probably more to come with many pharma companies awash with cash on their balance sheets and investment houses looking for place to shore up capital.

There are certainly some bargains to be had out there and Beximco Pharma is looking cheap at the current price imo.

237gmoney
22/4/2014
09:15
Also more consolidation in the Pharma world today.



Novartis and GSK to exchange assets and launch joint venture

Novartis and GlaxoSmithKline, two of the world's leading drugmakers, have agreed to exchange assets and combine their consumer healthcare units.

Novartis will acquire GSK's cancer drugs business for $16bn (£9.5bn) and sell its vaccines division, excluding the flu unit, to GSK for $7.1bn.

In a separate deal, Novartis has agreed to sell its animal health division to Lilly for nearly $5.4bn.

237gmoney
17/4/2014
12:22
Oh, I paid 15.1p for mine.
lomcovaks
17/4/2014
12:22
I topped up my holding today - only another 10k shares and still only a tiny, speculative total amount but I'm quite happy to sit here and see how events pan out over the next five to ten years.

Will continue to add on weakness but concur with the general views expressed by others that generics as a sector and the Bangladeshi market is a good position at the moment.

Good luck all holders.

lomcovaks
17/4/2014
11:03
The share price keeps rising now on small 2000 buys....very odd but then what would happen if someone came in with a 50k or 100k buy?

The share price finished up 3% in dhaka today but still hovering around the 50 BDT mark. Still c.40p over here.

237gmoney
16/4/2014
11:21
No worries Davy. Now I have my lot here happy to share anything I find.

It seems any buys at all lift the price at the moment so there can't be much free stock around at this price. Am hoping we see the 20s by results time which is only a month away now but there is no panic if we don't quite get there.

237gmoney
16/4/2014
11:07
thanks for finding and sharing all these 237gmoney
davydoo
16/4/2014
11:03
And Bangladesh looking to further exports/imports with Qatar and Turkey in the Pharma world



Bangladesh keen to boost trade ties with Qatar: Envoy

BANGLADESH can help Qatar in the pharmaceutical sector among other fields like ceramic products and garment industry, Ambassador of Bangladesh to Qatar HE Syed Mahmood Khundoker told Qatar Tribune recently.

Expressing his eagerness to boost trade ties with Qatar, the Bangladesh ambassador said,"Personally, I feel there is a tremendous scope for augmenting trade volumes between the two friendly countries." According to Khundoker, trade figures between the two countries currently stand at $170 million for the year 2012-13.




Fostering ties between Turkey and Bangladesh

Turkey can tap into the Bangladeshi pharmaceutical industry to benefit from competitive pricing and slash the huge social security bill in half by replacing Western suppliers with Bangladeshi ones on generic drugs. Ankara can also benefit from the quick disaster response Bangladesh has honed over years against natural disasters such as floods and cyclones. Similarly, the Turkish military, which has started to commit more troops to international missions, can learn a lot from its Bangladeshi counterparts on how to manage peacekeeping operations where Dhaka is the leading contributor around the world in all peacekeeping missions. Turkey and Bangladesh already work together well in defense, with cooperation dating back to 1978, when the two countries signed their first defense cooperation agreement. A bilateral military training agreement in 2004 carried defense cooperation to a higher level.

237gmoney
16/4/2014
11:00
It looks like more good news on the way



Dhaka working in WTO HQ for extension of TRIPS deadline.

237gmoney
15/4/2014
15:45
Our parent company leading the way in DTV....
237gmoney
10/4/2014
12:38
The buys keep coming in here (albeit relatively small amounts) but the market makers must be soon thinking of putting the price up? I don't have L2 here but we are now around a month away from 2013 year end numbers which I am expecting an EPS of over 4 again. It will be there or there abouts anyway.

We then should get Q1 2014 numbers and with taking the recent polictical troubles into account, I still expect sales growth based on exports to Europe and further afield.

It wouldn't be far out to expect a 20% stock dividend again with little or no movement in the GDR stock price in London due to the new found investors we have on the books. Likewise if there is no stock dividend I expect the share price to reflect the current financial performance both in Dhaka and in London due to the current discount to which we trade at in London compared to Dhaka.

237gmoney
09/4/2014
10:38
Our friend Richard Griffiths of Ora Capital partners and behind Barnard Nominees who now have over a 20% stake here has been dipping his fingers in the market elsewhere this week. Seems to be happy with his lot of Beximco for the present time.
237gmoney
08/4/2014
12:48
Good spot about the sector consolidation. Whether acquirer (likely) or acquired, should be a positive going forward for Beximco if consolidation does happen in Bangladesh.
microscope
08/4/2014
10:56
A good article has been posted on the Bangladesh economy if anyone is interested in that area.



Why Bangladesh will soon become a middle income nation

Including....

Why Bangladesh is forging ahead?

Bangladesh economy has undergone rapid changes over the last decade with growing export driven by RMG sector, along with flourishing manpower export, culminating in higher economic growth. These two economic drivers have been inclusive, given that the main economic agents are drawn heavily from the lowest rungs of the country's socio-economic strata. This has resulted in higher disposable income for population at the 'bottom of the pyramid.'

* Booming RMG sector currently employs 4 million workers, mostly women, who are generating almost 80% of the country's export. Mckinsey in its recent study on Bangladesh's RMG sector has predicted export earning nearing USD 40 billion mark within 2021. Sector growth is precipitating due to increasing labor costs in China and other competitors, leading them to move up the value chain. Bangladesh, providing the most inexpensive labor, has been the natural beneficiary of some shifting export orders. Despite rising minimum wage of c.77% this January, Bangladesh has managed to retain their least cost status.

* Many international investors have expressed strong interest in setting up factories in Bangladesh. Government is in talks with Chinese investors for setting up another special economic zone specifically for Chinese companies. Other companies also have expressed interest in investing in Bangladesh, especially considering country's large consumer base of 160 million and close proximity to China and India.

237gmoney
07/4/2014
08:45
Microscope, you mentioned sector consolidation last week, well today we had a bit of that - Not in Bangladesh but not far away.



Sun Pharmaceutical to acquire Ranbaxy in $4bn deal

India's Sun Pharmaceutical has agreed to acquire rival Ranbaxy - majority owned by Japan's Daiichi Sankyo - in an all-stock deal worth $4bn (£2.4bn).

The combined entity will be India's largest pharma company and the world's fifth-biggest generic drugs maker.

237gmoney
05/4/2014
10:47
Interesting, price being guided upwards by broker buying
envirovision
Chat Pages: Latest  50  49  48  47  46  45  44  43  42  41  40  39  Older

Your Recent History

Delayed Upgrade Clock